Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Amphivena Therapeutics

Amphivena Therapeutics is a bi-functional antibody therapy founded in 2012.

Overview Structured Data Issues Contributors Activity

amphivena.com

Is a

Company

Organization

Company attributes

Industry

Biopharmaceutical

Immunotherapy

Biomedical engineering

Engineering

Location

San Francisco

Email Address

info@amphivena.com

Phone Number

+16504993178

Investors

Clough Capital Partners

Tekla Capital Management

‌

StoneFund

MPM Capital

...

Founded Date

2012

Total Funding Amount (USD)

76,000,000

Latest Funding Round Date

September 2019

Latest Funding Type

Series C

Patents Assigned (Count)

Country

United States

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Amphivena Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.